Buyer's guide · August 2026
Institutional license cost: UpToDate institutional subscription, enterprise license and group subscription pricing
Nobody publishes these numbers. Here is what each vendor actually discloses, what moves the quote, and the questions that get a comparable price out of them.
We sell into this market and we publish our own per-clinician rate, including the multi-seat one.
Press Run check to see the interaction, contraindication, and dosing decision-support card for this scenario.
This on-page demo only ships with five illustrative scenarios and never invents clinical output, so it will not fake a card for this pair.
The full Prescriber.io desk checks any regimen against interactions, contraindications, and renal or hepatic dosing, with cited sources for you to verify.
Interaction
Contraindication / allergy check
Dosing guidance (renal / hepatic)
Guideline-based alternatives
Illustrative sample · not real clinical advice · you verify and decide
Clinician-in-the-loopDecision support for licensed clinicians. Prescriber.io does not diagnose or prescribe and is not a substitute for professional clinical judgment.
Check · flag · suggest · you review and sign off
The short answer
How much does an institutional license for a clinical drug reference cost?
No major clinical reference vendor publishes an institutional price. UpToDate directs medical groups and organizations with 20 or more users to enterprise sales, and its store shows no dollar figure for any tier until you select a country and a professional role. Lexidrug, Micromedex and DynaMed are all quoted per organization. The only published prices in the category are individual ones: UpToDate Lexidrug at $29.99 a month and epocrates+ at $179.99 a year, with Medscape and OpenEvidence free. Institutional quotes are driven by user count, licensed beds, number of sites, contract term and whether EHR integration is included, so the practical move is to run parallel quotes and demand a per-user figure at your exact headcount.
Prices are vendor-published list prices, re-verified at source in August 2026. Where a vendor publishes nothing, we say so rather than repeating a software-directory figure. Last updated August 2026.
What each vendor discloses
Institutional and group pricing, vendor by vendor
Eight tools, and the honest answer to "what will this cost my organization" for each one.
| Tool | Individual price | Institutional | How it is sold | The catch |
|---|---|---|---|---|
| UpToDate Wolters Kluwer | No published price | Quote only, 20+ users | The UpToDate store states plainly: "For medical groups and organizations with 20 or more users, explore our enterprise solutions or contact sales." Below that threshold you buy through the store, which asks you to select a country and a professional role before it will quote anything. | The store publishes no dollar figure anywhere, for any tier. There is also a separate "UpToDate for Healthcare Businesses" track for organizations that do not provide patient care, which is priced differently again. |
| UpToDate Lexidrug Wolters Kluwer | $29.99 / month | Negotiated, never published | The individual subscription is the one transparent price in this whole category: $29.99 a month in the US App Store, sold as the "Lexicomp Professional Package" or "Lexi-COMPLETE", after a one-month complimentary trial. Institutional agreements are negotiated separately and include the EHR integrations. | The reason institutions buy it is the integration into Epic, MEDITECH and Cerner, and that is exactly the part with no list price. Same vendor as UpToDate, opposite disclosure policy. |
| Epocrates+ athenahealth | $179.99 / year | Tiered by license count, quoted | Individual epocrates+ lists at $179.99 a year or $24.99 a month in the US App Store, and a free registered tier covers drug monographs, an interaction checker and a pill identifier. Group subscriptions are tiered by how many licenses you buy and quoted by athenahealth. | epocrates.com is restricted to US access, so you cannot even read the plan pages from outside the country. For a group, the published individual price is a useful ceiling: no group deal should cost more per head than $179.99. |
| Micromedex Merative | Not sold as a list item | Quote only | Micromedex is an institutional product first. It is bought by hospital pharmacy and drug information services, priced by organization, and quoted. | No published list price at any tier. The monthly figures that appear on software directories are not vendor numbers and disagree with each other, so treat them as noise. |
| DynaMed / DynaMedex EBSCO | Limited individual options | Quote only | Sold mostly through institutional agreements, often alongside a library's other EBSCO holdings. It is also bundled as a membership benefit by the American College of Physicians, which is worth checking before anyone buys a seat. | If your organization already licenses EBSCO databases, this is the one most likely to be cheaper to add than to buy standalone. |
| Medscape WebMD Health Corporation | Free | Not applicable | Free, ad-funded, with no in-app purchases at all. There is no institutional licence to buy because there is nothing to pay for. | You are the product: the funding model is pharmaceutical advertising. Some organizations care about that, most do not. |
| OpenEvidence OpenEvidence | Free | Not applicable | Free to NPI-verified US clinicians, ad-funded. The vendor announced full HIPAA compliance in April 2025 and handles protected health information under a BAA. | Vendor-level HIPAA capability does not mean your employer permits it. Several health systems instruct staff in writing not to enter PHI, because the organization has not signed acceptable BAA terms of its own. |
| Prescriber.io Prescriber.io | $39 / clinician / month | $29 / clinician / month, multi-seat | We publish the per-clinician price for every tier, including the multi-seat one: $39 for a solo prescriber, $29 per clinician for a practice or clinic on team seats, $59 for larger practices and pharmacies that need polypharmacy review and SSO, all billed annually. Enterprise agreements are quoted. | We are a decision-support tool for the prescribing moment, not a full clinical reference library. If what you need is long-form disease content to read, buy the reference and use us for the check. |
Vendor details reflect publicly published information as of August 2026. Products and prices change, so confirm current terms with each vendor before you sign.
What moves the number
Six things that decide your quote
None of these are on a price list. All of them are negotiable, and the second one is where most groups lose the most money.
Headcount, and how you count it
Almost every quote starts from the number of people who can log in. The negotiable part is who counts: prescribers only, or every nurse, resident, student and pharmacy technician with a badge. Organizations routinely get quoted on total staff when only a fraction will ever open the tool.
Beds, sites and legal entities
Hospital pricing often keys off licensed beds rather than users, and multi-site groups get priced per location. If your urgent care network runs fifteen storefronts under one tax ID, whether that is one site or fifteen is worth several thousand dollars a year.
Contract term
One-year deals price worst. Two and three-year terms buy a discount and, more usefully, a cap on renewal increases. Ask for the cap in writing; an uncapped renewal after a cheap first year is the oldest move in this category.
EHR integration
Launching a drug reference from inside Epic, MEDITECH or Cerner is usually a separately priced line item, not a feature of the base licence. It is also the line most likely to be dropped if you say you will start without it.
Content modules
The catalogue is rarely one product. Drug content, disease content, patient education, IV compatibility and toxicology may each be modules. Buying the bundle is convenient and is how the number gets large.
Remote and off-site access
IP-authenticated access on the hospital network is the cheap default. Off-site access, personal accounts and mobile app entitlement for staff at home are frequently priced on top, and they are the ones clinicians actually notice.
How to run it
Four steps, in this order
The first step costs nothing and regularly ends the project, because the access was already paid for.
Audit what you already hold
Before you talk to anyone, ask your medical librarian or clinical resources team for the current list. Health systems, residency programs and medical schools very often already license UpToDate, DynaMed, Lexidrug or Micromedex, and a surprising number of clinicians pay out of pocket for access their employer already provides.
Count who will genuinely use it
Pull real numbers before the first call: prescribers by service line, expected concurrent users, whether residents and students need accounts. Walking in with a defensible user count is the single biggest lever you have, because the alternative is being priced on your total headcount.
Get quotes in parallel, not in sequence
Because none of these vendors publish institutional rates, the only reference price you will ever have is another vendor's quote. Run them at the same time and say so. Ask each for a per-user cost at your exact headcount so the numbers are comparable.
Pilot before you sign the whole system
Ask for a scoped trial on one service line with usage reporting included. Utilization data from a pilot is what turns the renewal conversation from a negotiation into an arithmetic problem, and it tells you whether you are about to buy 4,000 seats for 300 regular users.
Who this is for
Six buyers, six different problems
The same contract behaves very differently depending on which of these you are.
Health systems and hospitals
Usually buying through pharmacy and the medical library together, priced on beds or total staff, and wanting the EHR integration. The recurring problem is paying for system-wide seats that a minority of staff ever open.
Urgent care and multi-site groups
The hardest segment to price, because they are too large for the individual store and too small to interest enterprise sales. Whether your sites are counted as one entity or many is the whole negotiation.
Medical libraries and universities
Buying for a population that turns over every year, with IP-authenticated and off-site access both mandatory, and usually holding an existing vendor relationship that can absorb another database more cheaply than a new contract.
Residency and training programs
Small, fixed cohorts with a hard July turnover date. Ask about trainee rates directly, because several vendors price residents and students far below staff physicians but do not advertise it.
Group practices and clinics
Ten to fifty prescribers, no procurement department, and no appetite for a six-week sales cycle. This is the group most likely to overpay by simply renewing individual subscriptions one clinician at a time.
Retail and specialty pharmacy
Depth of drug content matters more than disease content here, which usually means Lexidrug or Micromedex rather than a general reference, and IV compatibility or compounding modules may be the reason for the contract at all.
Put these in the RFP
Ten questions that get you a comparable number
Because no institutional price is published, the only benchmark you will ever hold is another vendor's quote for the same headcount. That makes the wording of the question more important than the negotiation that follows.
Ask every vendor the same ten things, in writing, and insist on a per-user figure. A total contract value tells you nothing you can compare.
- 01 What is the per-user cost at exactly our headcount, and at half of it?
- 02 Is the price driven by users, licensed beds, sites or FTEs, and which definition are you applying to us?
- 03 What is the maximum renewal increase, in writing, for the full term?
- 04 Is EHR integration included or a separate line, and what does implementation cost?
- 05 Which content modules are in this quote and which are upsells later?
- 06 Does the price include off-site access and the mobile apps for staff at home?
- 07 Do residents, students and part-time staff need full-price seats?
- 08 Will you provide utilization reporting we can use at renewal?
- 09 Can we run a scoped pilot on one service line first, and does it credit against the contract?
- 10 If we already license other products from you, what does adding this one cost rather than buying it standalone?
Why there is no price list for any of this
Try to find out what UpToDate costs and you run into the same wall everyone else does. The store will not quote you until you have told it which country you are in and what your professional role is, and even then the institutional path does not produce a number at all. It produces a sales contact. The page says it plainly: for medical groups and organizations with 20 or more users, explore enterprise solutions or contact sales.
This is not an oversight. Quote-only pricing lets one vendor charge a 900-bed academic medical center and a twelve-provider clinic completely different amounts for identical content, and it prevents any published figure from becoming a ceiling in the next negotiation. Every enterprise software category does this. What makes it more frustrating here is that the same vendor sells the same drug data two ways: Lexidrug's individual subscription price is public at $29.99 a month, while the institutional agreement that includes the Epic and Cerner integrations is not published anywhere.
The practical consequence for you is that the burden of producing a comparable number has been moved onto the buyer. Software directories fill that gap with confident figures that no vendor ever published, and those figures contradict each other by hundreds of dollars for the same product. Do not build a budget on them.
The 20-user line, and what happens if you sit just under it
Twenty users is the published threshold at which UpToDate moves you from the store to enterprise sales. Groups sitting a little under it have a genuine choice, and it is worth doing the arithmetic both ways. Small-group rates through the store are discounted by user count and can be bought this week. An enterprise agreement takes weeks, involves procurement, and only starts paying off when you have enough seats for the volume discount to overtake the overhead.
The trap is the group that sits just above the line without noticing. A fifteen-clinic urgent care network with twenty-five prescribers is, on paper, an enterprise customer, and will be quoted like one. It has none of the negotiating weight of a health system and none of the simplicity of the store. If that describes you, the site-counting question in the table above is the one to settle before any other, because whether your locations count as one organization or fifteen can move the quote by more than every other variable combined.
Check what your organization already licenses first
This is the least interesting advice on this page and the most likely to save you real money. Hospital libraries, health systems, residency programs and medical schools very frequently already hold licenses for UpToDate, DynaMed, Lexidrug or Micromedex. Access usually runs through an institutional login and often works off-site, and a great many clinicians quietly pay out of pocket every year for something their employer already provides.
Ask your medical librarian, or open your institution's clinical resources page, before you renew anything or start a procurement. Then buy against whatever gap is genuinely left. If the gap is long-form disease content to read, buy the reference. If it is fast drug facts, the free tiers and a $179.99 app cover a lot of ground, as our comparison of drug reference apps by role sets out with every published US price, and the full comparison of clinical decision support software covers the wider category.
What we charge, and why we publish it
We publish every per-clinician rate we have, including the multi-seat one: $39 per clinician per month for a solo prescriber, $29 per clinician on team seats for a practice or clinic, and $59 for larger practices and pharmacies that need polypharmacy review and single sign-on, all billed annually. Larger health-system agreements are quoted, and we will tell you the per-user number when we quote them.
We are not a replacement for a clinical reference library, and this page would be dishonest if it implied otherwise. Prescriber.io is built for the prescribing moment: you enter the drug or the scenario once, and the interaction check, contraindication and allergy flags, renal and hepatic dose adjustments and guideline-based alternatives come back together in one card with sources cited on each flag. Every flag is a prompt for a licensed clinician who verifies against official sources and signs. If your organization needs somebody to read a monograph, it still needs a reference. If it needs the check to happen reliably before the signature, that is a different purchase, and it is the one we are for.
See the check run before you brief procurement
Interactions, contraindications, renal and hepatic dosing and guideline alternatives, in one card your clinicians review and sign off on.
Good questions
Institutional licensing, answered
Go deeper
Costs, head to head
Lexicomp subscription price
The one published price in the category, and what the institutional version adds.
CostUpToDate cost
Why no individual figure is published either, and what the store will and will not tell you.
CostEpocrates cost
The free tier, epocrates+ at $179.99 a year, and how group tiers are quoted.
CompareUpToDate vs Epocrates
The reference against the drug lookup, for groups deciding which job to buy for.
CompareEpocrates vs Lexicomp
Two drug references at very different price points, compared on depth.
PricingPrescriber.io pricing
Every per-clinician rate we charge, published, including team seats.
Whatever your organization licenses, the checks still have to happen.
Prescriber.io checks interactions, flags contraindications, surfaces renal and hepatic dosing and suggests guideline-based alternatives, with cited sources. Your clinicians review, verify, and sign.
Decision-support for licensed clinicians. Prescriber.io does not diagnose or prescribe autonomously and is not a substitute for professional clinical judgment. Always verify against official sources.